Mutual fund · Sectoral / Thematic
HDFC Pharma and Healthcare Fund
₹3,501 cr across 37 positions, as filed for 2026-09-30. Returns are the fund's AMFI growth-plan NAV; holdings and behavior come from its filed monthly portfolios.
Returns, against the category
Q2 FY27: +26% over 1 year against the median Sectoral / Thematic fund's +2%.
| Over | Quarter | 1 year | 3 years (ann.) | 5 years (ann.) |
|---|---|---|---|---|
| HDFC Pharma and Healthcare Fund | +4% | +26% | — | — |
| Median Sectoral / Thematic fund | −2% | +2% | +12% | +11% |
—Q3 FY24—Q4 FY24—Q1 FY25—Q2 FY25+50%Q3 FY25+30%Q4 FY25+28%Q1 FY26+4%Q2 FY26+1%Q3 FY26+7%Q4 FY26+21%Q1 FY27+26%Q2 FY27
What moved the fund, last 12 filed months
Contribution = the fund's filed weight each month × that stock's price move in its own filings, in percentage points of NAV. Corporate-action months are left out.
| Stock | 12 months | Latest month |
|---|---|---|
| Divis Laboratories Ltd. | +3.7 pp | −0.2 pp |
| Acutaas Chemicals Limited | +3.1 pp | +0.1 pp |
| Shilpa Medicare Ltd | +1.7 pp | +0.3 pp |
| Laurus Labs Ltd. | +1.7 pp | 0.0 pp |
| Sun Pharmaceutical Industries Ltd. | +1.5 pp | −0.8 pp |
| Stock | 12 months | Latest month |
|---|---|---|
| Eris Lifesciences Ltd | −1.0 pp | −0.1 pp |
| Max Healthcare Institute Limited | −0.8 pp | −0.4 pp |
| Jupiter Life Line Hospitals Limited | −0.5 pp | −0.3 pp |
| Laxmi Dental Limited | −0.5 pp | −0.0 pp |
| Aster DM Quality Care Limited | −0.4 pp | −0.3 pp |
Holdings, as filed for 2026-09-30
| Holding | Sector | % of fund | Value | Held for | Vs avg cost |
|---|---|---|---|---|---|
| Divi's Laboratories Limited | Healthcare | 9.39% | ₹329 cr | 33 mo | +61% |
| Sun Pharmaceutical Industries Limited | Healthcare | 8.28% | ₹290 cr | 35 mo | +10% |
| Alkem Lab | Healthcare | 4.64% | ₹163 cr | 21 mo | -0% |
| Cipla Limited | Healthcare | 4.15% | ₹145 cr | 6 mo | +1% |
| Apollo Hospitals Enterprise Limited | Healthcare | 3.69% | ₹129 cr | 3 mo | -3% |
| Torrent Pharmaceuticals Limited | Healthcare | 3.65% | ₹128 cr | 3 mo | -6% |
| Max Healthcare Institute Limited | Healthcare | 3.61% | ₹126 cr | 35 mo | -12% |
| Aster DM Healthcare Limited | Healthcare | 3.56% | ₹125 cr | 34 mo | +35% |
| Lupin Limited | Healthcare | 3.55% | ₹124 cr | 35 mo | +12% |
| Neuland Laboratories Limited | Healthcare | 3.24% | ₹114 cr | 7 mo | +42% |
| Shilpa Medicare Limited | Healthcare | 3.23% | ₹113 cr | 12 mo | +212% |
| Dr. Reddy's Laboratories Limited | Healthcare | 3.19% | ₹112 cr | 4 mo | +0% |
| Acutaas Chemicals Limited | Healthcare | 3.18% | ₹111 cr | 18 mo | +182% |
| Anthem Biosciences Limited | Healthcare | 3.17% | ₹111 cr | 15 mo | +18% |
| IPCA Laboratories Limited | Healthcare | 2.98% | ₹104 cr | 35 mo | +43% |
How this fund actually behaves
Computed from every filed monthly portfolio (35 months of filings) by the research pipeline.
| Holding patience | Median months a position is held (25th–75th band) | 8 mo (3–12) |
| Win rate on exits | Closed positions sold above entry, and the payoff ratio (20 exits) | 60% · payoff 1.0× |
| Loser handling | Cuts losers vs averages down, from 12 months of filings | Averages down |
| Entry valuation discipline | Median P/E paid on entries over 36 months; share above 50× | 59× · 56% over 50× |
| Portfolio valuation today | Weighted P/E and P/B of the current book at filed prices | 79.1× P/E · 10.8× P/B |
| Churn | Stocks entered and exited in 12 months, of 37 positions | 20 in · 12 out |
| Concentration | Top 10 holdings' share; effective number of positions | 48% · ~24 effective |